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Hemolysis is an inevitable side effect of cardiopulmonary
bypass resulting in increased plasma free hemoglobin that
may impair tissue perfusion by scavenging nitric oxide. Acute
kidney injury after on-pump cardiovascular surgery arises
from a number of causes and severely affects patient
morbidity and mortality. Here, we studied the effect of acute
hemolysis on renal injury in 35 patients undergoing on-pump
surgical repair of thoracic and thoracoabdominal aortic
aneurysms of whom 19 experienced acute kidney injury.
During surgery, plasma free hemoglobin increased, as did
urinary excretion of the tubular injury marker N-acetyl-b-D-
glucosaminidase, in patients with and without acute kidney
injury, reaching peak levels at 2 h and 15min, respectively,
after reperfusion. Furthermore, plasma free hemoglobin was
independently and significantly correlated with the urine
biomarker, which, in turn, was independently and
significantly associated with the later postoperative increase
in serum creatinine. Importantly, peak plasma free
hemoglobin and urine N-acetyl-b-D-glucosaminidase
concentrations had significant predictive value for
postoperative acute kidney injury. Thus, we found an
association between increased plasma free hemoglobin and
renal injury casting new light on the pathophysiology of
acute kidney injury. Therefore, free hemoglobin is a
new therapeutic target to improve clinical outcome after
on-pump cardiovascular surgery.
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Acute kidney injury (AKI) is an important complication of
major cardiovascular surgery that affects 3–48% of patients
and is independently associated with mortality.1–3 At present,
specific therapies for postoperative AKI are not available,
and patients generally receive supportive care until renal
function has recovered spontaneously.4 The development of
novel interventions to reduce AKI after major cardiovascular
surgery requires a detailed knowledge of its pathophysiology,
which is characterized by a complex interplay of renal vascular
dysfunction, tubular epithelial injury, and inflammation.5
In cardiovascular surgery, the use of cardiopulmonary
bypass is associated with AKI.6,7 Hemolysis is a common
consequence of cardiopulmonary bypass that is caused by
mechanical stress in the perfusion circuit and results in the
release of hemoglobin from lysed erythrocytes into the
plasma.8,9 Cell-free oxyhemoglobin reacts with nitric oxide to
form methemoglobin and nitrate. As nitric oxide is an
important vasodilator that has a central role in blood flow
regulation, reduction of nitric oxide bioavailability by free
hemoglobin (fHb) may impair tissue perfusion.10 Indeed,
addition of 6 mmol/l oxyhemoglobin to the perfusion
solution of isolated rabbit hearts completely eliminates the
activity of endothelium-derived nitric oxide.11 In line with
this finding, patients with chronic hemolysis due to sickle cell
disease are characterized by an attenuated increase in forearm
blood flow after infusion of the nitric oxide donor sodium
nitroprusside as compared with healthy volunteers; forearm
blood flow response was reduced by 80% in patients with
plasma fHb concentrations 46 mmol/l.10,12 In addition, after
glomerular ultrafiltration, urine fHb may cause AKI by
generating reactive oxygen species and by aggregating into
casts in the tubular lumen.13,14
Until now, human studies have focused on the association
between urinary fHb and AKI.13 The vasoconstrictive effects
of fHb in the plasma may provide an additional explanation
for hemolysis-induced renal injury. In the current study, we
show that increased plasma fHb concentrations are indepen-
dently associated with injury to the proximal tubular
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epithelium during open surgical repair of thoracic and
thoracoabdominal aortic aneurysms with cardiopulmonary
bypass. Moreover, plasma fHb levels 2 h after surgery
predicted AKI in the early postoperative period. This finding
sheds new light on the pathophysiology of AKI and offers a
novel therapeutic target to improve clinical outcome after
major cardiovascular surgery.
RESULTS
Open repair of thoracic and thoracoabdominal aortic
aneurysms with cardiopulmonary bypass causes AKI
We studied 35 consecutive patients undergoing open repair
of a thoracic aortic aneurysm (N¼ 1) or thoracoabdominal
aortic aneurysm (N¼ 34) with cardiopulmonary bypass.
Clinical data are presented in Table 1. None of the patients
were diagnosed with preoperative hemolytic disease. Overall,
the in-hospital mortality was 20% (N¼ 7), and there were no
intra-operative deaths. A total of 19 patients (54%)
developed postoperative AKI (Table 1) as defined by the
AKIN (AKI Network) classification. Mortality was numeri-
cally higher in AKI patients than in those without AKI (32%,
N¼ 6; vs 6%, N¼ 1), but this difference did not reach
statistical significance (P¼ 0.10). Renal function fully recov-
ered during hospitalization in 85% (N¼ 11 out of 13) of the
surviving AKI patients. In the remaining two AKI patients,
renal function improved from stage 3 to stage 2. The impact
of AKI on overall patient outcome was reflected by a trend
toward longer hospitalization times (21 (13–34) days vs 14
(12–16) days, P¼ 0.05), and intensive care unit admission
times (7 (4–28) days vs 4 (3–7) days, P¼ 0.11) in AKI vs non-
AKI patients, respectively. Baseline renal function (estimated
glomerular filtration rate (eGFR) estimated by the abbre-
viated Modification of Diet in Renal Disease equation15) did
not differ between patients with or without postoperative
Table 1 | Characteristics of patients undergoing open surgical repair for thoracic or thoracoabdominal aortic aneurysms with
cardiopulmonary bypass
Non-AKI (N=16) AKI (N=19) P-value
Preoperative variables
Age (years), median (IQR) 58 (54–66) 68 (56–72) 0.14
Male, n (%) 9 (56) 14 (74) 0.31
Indication, n (%) — — 0.04
TAA 1 (6) 0 (0)
TAAA type Ia 2 (13) 1 (5)
TAAA type IIa 2 (13) 9 (47)
TAAA type IIIa 7 (44) 5 (21)
TAAA type IVa 1 (6) 0 (0)
TAAA type Va 3 (19) 5 (26)
Concomitant aortic disease, n (%) — — 0.50
Type B dissection (Stanford classification) 2 (13) 4 (21)
Marfan disease 2 (13) 1 (5)
Aortic stenosis (high grade) 2 (13) 0 (0)
eGFR (ml/min per 1.73m2)b, mean±s.d. 77±30 95±43 0.28
Chronic kidney disease (eGFRo60), n (%) 8 (28) 9 (31) 0.70
Intra-operative variables
Selective organ perfusion, n (%) 14 (88) 19 (100) 0.20
Total operation time (min), mean±s.d. 369±92 433±96 0.06
Cardiopulmonary bypass time (min), mean±s.d. 163±56 195±64 0.14
Aortic cross clamp time (min), mean±s.d. 114±58 144±71 0.21
Blood loss (L), median (IQR) 8 (5–25) 8 (6–21) 0.86
Packed cell transfusion (n 350ml units), median (IQR) 10 (7–16) 10 (7–18) 0.95
Postoperative variables
In-hospital mortality, n (%) 1 (6) 6 (31) 0.10
Total intensive care unit stay (days), median (IQR) 4 (3–7) 7 (4–28) 0.11
Total hospitalization time (days), median (IQR) 14 (12–16) 21 (13–34) 0.06
Creatinine change o48 h (%), median (IQR) 115 (93–129) 243 (166–300) o0.001
Acute kidney injury (stage 1, 2, or 3 of AKIN classification), n (%) — 19 (100) —
Stage 1 — 6 (32) —
Stage 2 — 4 (21) —
Stage 3 — 9 (47) —
Dialysis — 7 (37) —
Abbreviations: AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; eGRF, estimated glomerular filtration rate; IQR, interquartile range from the 25th to the 75th
percentile; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aortic aneurysm.
aRoman numerals refer to the TAAA classification system by Crawford37; see also the ‘Materials and Methods’ section.
bGlomerular filtration rate was estimated by the abbreviated Modification of Diet in Renal Disease (MDRD) as recommended by the National Kidney Foundation.15
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AKI (95±43 and 77±30 ml/min per 1.73 m2, respectively,
P¼ 0.28).
Open repair of thoracic and thoracoabdominal aortic
aneurysms results in hemolysis
To study the development of hemolysis during surgery,
plasma fHb levels were analyzed at eight preset perioperative
time points from preoperative until the second postoperative
day. Preoperative fHb levels were comparable with values
measured in healthy subjects (o4 mmol/l). At the end of
cardiopulmonary bypass, plasma fHb levels had increased
significantly in AKI patients (Po0.05) compared with
baseline values (Figure 1a). Plasma fHb values further
increased in both groups in the first few hours after cessation
of cardiopulmonary bypass (Po0.001) and remained
elevated above the preoperative level during the first two
postoperative days. Comparison of plasma fHb levels
between patients with and without postoperative AKI
(Figure 1b) showed that at 2 h after reperfusion, plasma
fHb levels were significantly higher in AKI patients (16.6±
12.4 vs 7.9±4.2 mmol/l, Po0.05). Overall, plasma fHb
concentrations of X6 mmol/l, levels associated with a
reduction in microcirculatory blood flow, were measured in
83% of patients at any time point during the study period.
Urine fHb was undetectable (o2 mmol/l) in all patients,
suggesting that glomerular filtration of fHb is unlikely to be a
major contributor to AKI after cardiovascular surgery.
Hemolysis is correlated with renal tubular injury during open
repair of thoracic and thoracoabdominal aortic aneurysms
To study renal tubular injury during surgery, urinary
N-acetyl-b-(D)-glucosaminidase (NAG) concentration was
measured and corrected for urinary creatinine. NAG is a
lysosomal brush border enzyme present in proximal tubular
epithelial cells that are particularly vulnerable to ischemic
injury.16 Parallel to the development of hemolysis, a signi-
ficant increase in urine NAG was observed during cardio-
pulmonary bypass (Figure 1b). NAG levels remained elevated
above preoperative levels until the second postoperative day.
Moreover, when comparing patients with and without AKI,
significantly higher urine NAG levels were detected in
patients with AKI at 15 min after reperfusion (39.6±45.0
vs 12.5±7.7 Units/mmol creatinine, Po0.05).
Next, we analyzed the association between hemolysis and
renal tubular injury. To this end, the area under the curve of
fHb (AUCfHb) and NAG (AUCNAG) was calculated, reflecting
total fHb release and NAG excretion during the study period.
Both AUCfHb and AUCNAG showed a strong positive
correlation (Figure 2, Pearson’s r¼ 0.75, Po0.0001). This
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Figure 1 |Hemolysis and renal damage during open thoracic
or thoracoabdominal aortic repair. (a) Hemolysis and (b) renal
proximal tubular epithelial damage during open thoracic or
thoracoabdominal aortic repair in patients with (N¼ 19) and
without (N¼ 16) acute kidney injury. Urinary NAG concentrations
were corrected for urine creatinine values. *Po0.05, **Po0.01,
***Po0.001 compared with preoperative levels. #Po0.05
between AKI and non-AKI patients. AKI, acute kidney injury; CPB,
cardiopulmonary bypass; fHb, free hemoglobin, NAG, N-acetyl-b-
D-glucosaminidase; R, reperfusion.
r =0.75
P<0.0001
AUCfHb
AU
C N
AG
/c
re
at
in
in
e
10,000
1000
100
10
1
1000 10,000100101
Figure 2 |Correlation of total plasma fHb release and urinary
NAG excretion during the entire study period. Data were log
transformed before entering into the Pearson’s correlation test.
AUC, area under the curve; fHb, free hemoglobin; NAG; N-acetyl-b-
D-glucosaminidase.
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correlation remained when the subgroups of AKI and
non-AKI patients were analyzed separately (Pearson’s
r¼ 0.79, Po0.001 and r¼ 0.64, Po0.01, respectively).
Finally, AUCfHb remained significantly associated with
AUCNAG (P¼ 0.001, Table 2) after adjustment for cardio-
pulmonary bypass time—a potential confounder—in multi-
variable linear regression.
Hemolysis and renal tubular injury are associated with
postoperative renal dysfunction
To assess whether intra-operative renal tubular injury was
associated with postoperative AKI, we analyzed the relationship
between NAG levels (at 15 min reperfusion) and perioperative
serum creatinine changes (the highest value reached within the
first two postoperative days as a percentage from baseline).
Using multivariable linear regression, we studied the associa-
tion of NAG with creatinine increase independently of three
established risk factors for AKI, namely preoperative age,
preoperative eGFR, and intra-operative cardiopulmonary
bypass time. NAG levels (P¼ 0.002), preoperative eGFR
(P¼ 0.03), and age (P¼ 0.01) were significantly associated
with serum creatinine increases (Table 3).
To study the prognostic value of plasma fHb and urine
NAG for postoperative AKI, we analyzed the sensitivity and
specificity of peak plasma fHb and urine NAG using receiver-
operating characteristic curves (Figure 3). Peak fHb and NAG
values were observed at 2 h and 15 min of reperfusion,
respectively. Peak plasma fHb and urine NAG both held
significant diagnostic power for the prediction of AKI (AUC
0.73, P¼ 0.04 and AUC 0.76, P¼ 0.01, respectively). Optimal
cutoff values to discriminate between patients with and
without AKI were 10 mmol/l for plasma fHb (sensitivity: 79%,
specificity: 69%) and 14 Units/mmol creatinine for urinary
NAG (sensitivity: 73%, specificity: 72%). This indicates that
it is possible to differentiate between patients with and
without postoperative AKI on the basis of plasma fHb levels
shortly after surgery.
DISCUSSION
AKI is a common complication after surgery using
cardiopulmonary bypass with a profound impact on post-
operative morbidity and mortality.17 Despite major improve-
ments in biocompatibility and flow performance of the
bypass circuits, the incidence of AKI after cardiovascular
surgery has not decreased significantly over the past decade.18
Therefore, development of novel interventions to reduce AKI
after major cardiovascular surgery requires further study of
its pathophysiology.
In the current study, we show that the concentrations of
plasma fHb and urine NAG increased during on-pump repair
of thoracic and thoracoabdominal aortic aneurysms, which
indicates that hemolysis and tubular epithelial injury
occurred. Hemolysis during cardiac surgery has previously
been reported and is considered to be caused by cardiopul-
monary bypass circuits, transfusion of stored red blood cells,
and cell salvage devices.8,19–21 Interestingly, we found that the
total release of plasma fHb was independently correlated with
urine NAG, which in turn was independently associated with
the postoperative increase in serum creatinine. This clinical
observation is supported by rodent experiments in which
intravenous infusion of fHb increased urine NAG concentra-
tions 10-fold, while decreasing GFR by 30%.22 Furthermore,
scavenging of plasma fHb by infusion of haptoglobin in
patients undergoing cardiac surgery was associated with a
four-fold reduction in urine NAG as compared with a
historical cohort without haptoglobin infusion.23 In addition,
cardiac surgery without cardiopulmonary bypass, which is
expected to attenuate intravascular hemolysis, causes a
significant reduction in postoperative AKI as compared with
on-pump surgery.24 In our study, peak plasma fHb levels
X10 mmol/l held a significant diagnostic value for the
Table 2 |Multivariable linear regression analysis for AUCNAG
Variable Beta 95% CI P-value
Cardiopulmonary bypass time (min) 0.11 2.30–2.51 0.93
AUCfHb 1.31 0.57–2.05 0.001
Abbreviations: AUC, area under the curve; CI, confidence interval; fHb, plasma free
hemoglobin; NAG, N-acetyl-b-D-glucosaminidase.
Table 3 |Multivariable linear regression analysis for
perioperative creatinine changea
Variable Beta 95% CI P-value
Age (years) 3.34 0.97–5.71 0.01
Preoperative eGFR (ml/min per 1.73m2) 0.91 0.10–1.73 0.03
Cardiopulmonary bypass time (min) 0.01 0.54–0.52 0.97
NAG15min R (Units/mmol creatinine) 1.53 0.61–2.46 0.002
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate;
NAG, N-acetyl-b-D-glucosaminidase; 15min R, 15min after reperfusion.
aCreatinine change expressed as change from baseline to highest value reached
during the first two postoperative days in percentage (%).
Peak plasma fHb (AUC 0.73, P=0.04)
Peak urine NAG (AUC 0.76, P=0.01)
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Figure 3 |Receiver-operating characteristics (ROC) curve
presenting sensitivity and 1-specificity for peak plasma fHb
levels at 2 h reperfusion (black line) and peak urine NAG
levels at 15min reperfusion (dotted line). AUC, area under the
receiver-operating characteristics curve; fHb, free hemoglobin;
NAG, N-acetyl-b-D-glucosaminidase.
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prediction of AKI. The sensitivity and specificity of this
marker to predict AKI in clinical practice should be validated
in future studies. Taken together, these findings indicate that
plasma fHb is a risk factor for tubular epithelial damage and
AKI after cardiovascular surgery.
The diagnosis of AKI using serum creatinine is difficult, as
serum creatinine is a poor marker of early renal dysfunction
in the nonsteady state of the surgical patient. As the impact of
AKI on the outcome of the patient is profound, the quest for
sensitive and specific biomarkers has been designated as
priority. During the past decade, several candidate biomar-
kers (such as neutrophil gelatinase-associated lipocalin,
kidney injury molecule-1, and interleukin-18) were reported;
however, none of them have been generally accepted for
clinical use. The diagnostic accuracy of urine NAG and
plasma fHb in the current study might provide a valuable
tool for early detection of postoperative AKI, enabling timely
therapeutic interventions.25 Nevertheless, sensitivity and
specificity may be overestimated when calculated with the
same data set that has been used to determine the optimal
cutoff point for a diagnostic test. Therefore, the diagnostic
accuracy of our suggested cutoff point for plasma fHb should
be validated in future studies.
The observed relationship between plasma fHb and
renal damage in this human setting is important as earlier
studies on hemolysis-induced AKI focussed traditionally on
the role of filtered fHb in urine.13,26,27 Indeed, urine fHb and
its catabolic products iron and heme catalyze the generation
of reactive oxygen species that damage the tubular epithelium
when present in the glomerular ultrafiltrate.14 In support of
this, administration of the iron scavenger deferoxamine
attenuated the glomerular and tubular dysfunction induced
by intravenous administration of fHb in rats.28 Similarly,
reduced plasma ferritin concentrations—which may be
associated with reduced iron scavenging—were associated
with increased AKI after human cardiovascular surgery.21
Second, fHb may precipitate in the acidic ultrafiltrate,
forming casts that obstruct the tubular lumen and reduce
glomerular filtration.14,29 Prevention of cast formation by
alkalinization of the urine reduced tubular injury and
glomerular dysfunction after intravenous fHb infusion in
rats.14 As fHb was not detected in urine samples of our
patients, we propose that the glomerular filtration of fHb is
unlikely to be a major contributor to AKI.
An additional and complementary explanation for the
induction of renal injury by hemolysis is provided by the
recent discovery that plasma oxy-fHb converts the vasodi-
lator nitric oxide into biologically inactive nitrate.10 As nitric
oxide has a central role in blood flow regulation, reduction of
nitric oxide bioavailability by fHb may impair tissue
perfusion and induce AKI. In line with this observation,
induction of hemolysis by water infusion or direct admini-
stration of fHb in dogs increased plasma nitric oxide
consumption and resulted in elevated systemic vascular
resistance and reduced creatinine clearance. These hemody-
namic effects of acute hemolysis were attenuated by nitric
oxide inhalation, which converts oxy-fHb into biologically
inactive methemoglobin.12 Furthermore, in patients with
chronic hemolytic disorders such as sickle cell disease and
malaria, the extent of hemolysis was correlated with
endothelial dysfunction, pulmonary hypertension, and coa-
gulation.30–32
In the light of these findings, we propose that the
association between acute hemolysis and renal injury in
patients undergoing on-pump cardiovascular surgery may be
caused by scavenging of nitric oxide through fHb. First,
plasma fHb levels in our study are comparable with
concentrations reported to reduce blood flow, nitric oxide
bioavailability, and impair renal function in animal experi-
ments and men.10,12 Second, in patients after on-pump
surgical repair of thoracic and thoracoabdominal aortic
aneurysms, we found that the increase in forearm blood flow
after infusion of the nitric oxide donor sodium nitroprusside
was significantly lower at the time of peak plasma fHb
concentration as compared with the increase at 1 day after
surgery. As the vascular response to acetylcholine—with
vasodilatory effects that are largely independent of nitric
oxide—was similar at these time points, the impaired
reactivity to sodium nitroprusside is most likely not caused
by vascular dysfunction but rather by reduced bioavailability
of the administered nitric oxide donor (Hanssen et al.,
submitted). These data, although providing indirect proof,
support our findings and suggest that scavenging nitric oxide
by plasma fHb may contribute to the association between
acute hemolysis and renal injury.
The major strength of the current study is its translation
of experimental findings on the effects of hemolysis on renal
function into the clinical setting of on-pump cardiovascular
surgery. Patients undergoing open repair of thoracic and
thoracoabdominal aortic aneurysms are particularly suitable
for clinical investigation of the pathophysiology of AKI, as
these individuals are at exceptionally high risk of post-
operative renal dysfunction. The strong and significant
correlations between hemolysis and renal injury in our
patients should not be interpreted as causal relationships.
The results from the current study require further analysis in
larger patient groups, and interventional studies using
haptoglobin infusion or nitric oxide inhalation to inactivate
fHb or using nitrite administration to increase nitric oxide
bioavailability may provide further support for a causal
relationship between nitric oxide scavenging by plasma fHb
and AKI after on-pump cardiovascular surgery.12,23,33,34 The
pathophysiology of AKI is highly complex and involves
multiple factors other than intravascular hemolysis, such as
ischemia and reperfusion, hemodilution, inflammation, and
baseline renal function.5 The current study provides addi-
tional insights into the pathophysiology of this condition
relevant for the design of multivariable risk scores and future
therapeutic studies.
In conclusion, we show that increased plasma fHb
concentrations are independently associated with injury to
the proximal tubular epithelium during surgery with
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cardiopulmonary bypass. Peak plasma fHb concentrations 2 h
after surgery were predictive of AKI within the first
postoperative days. This finding sheds new light on the
pathophysiology of AKI during on-pump cardiovascular
surgery that may also have a role in other conditions
associated with acute hemolysis, such as hemodialysis and
major trauma.35,36
MATERIALS AND METHODS
Patients
Patients admitted to the Maastricht University Medical Center or
University Hospital Aachen between May 2006 and November 2008
to undergo elective open repair of a thoracic aortic aneurysm or
thoracoabdominal aortic aneurysm with cardiopulmonary bypass
were included. The study was approved by the Institutional Review
Board of both institutes, and written informed consent was obtained
from every patient before surgery.
Patients requiring preoperative dialysis due to preexistent renal
failure were excluded.
Preoperative clinical data were prospectively collected from the
patient’s medical record.
eGFR was estimated by the abbreviated Modification of Diet in
Renal Disease as recommended by the National Kidney Founda-
tion.15 Thoracoabdominal aortic aneurysm type was classified
according to Crawford’s classification. Type I thoracoabdominal
aortic aneurysms extend distally from the left subclavian artery, in
any case above the sixth intercostal space, down to encompass the
aorta at the origin of the celiac trunk and superior mesenteric artery.
The renal arteries may also be involved, but the aneurysm does not
extend into the infrarenal segment. Type II thoracoabdominal aortic
aneurysms extend distally from the left subclavian artery till the
aortic bifurcation. Type III thoracoabdominal aortic aneurysms
begin in the distal half of the descending thoracic aorta, below the
sixth intercostal space, and extend to the aortic bifurcation. Type IV
aneurysms involve the entire abdominal aorta from the diaphragm
to the bifurcation. Type V thoracoabdominal aortic aneurysms
originate from the lower thoracic aorta to the aortic section just
below the visceral arteries.37
Surgical procedure
An indwelling radial artery catheter was placed as part of standard
anesthetic care. After induction, patients were placed in a left helical
position. Thoracolaparotomy in types I, II, and III thoracoabdom-
inal aortic aneurysms was performed through the sixth intercostal
space. In type IV thoracoabdominal aortic aneurysms, a small
thoracolaparotomy through the eighth intercostal space sufficed. In
patients with an isolated thoracic aneurysm, a small laparotomy was
performed. Surgical repair was typically performed from proximal
to distal. After heparinization (0.5 mg/kg), cardiopulmonary bypass
was established using a centrifugal pump with membrane oxygena-
tion (Jostra Rotaflow with Jostra Quadrox, Maquet Cardiopulmon-
ary AG, Hirrlingen, Germany). Depending on the extent of the
aneurysm, cardiopulmonary bypass was expanded with a four-
branched tubing system enabling pressure-controlled perfusion with
oxygenated blood of the celiac trunk, superior mesenteric artery,
renal arteries, and if necessary intercostal arteries, during aortic cross
clamping. During aortic cross clamping, renal blood flow and perfusion
pressure was closely monitored and kept at 200–280 ml/min, and
60–70 mm Hg, respectively. A cell-salvage device (CATS, Fresenius
SE, Bad Homburg, Germany) was used in every patient. The exact
surgical protocol was identical in both institutions and has been
described in detail elsewhere.38,39 Postoperatively, all patients were
transported to the Cardiothoracic Intensive Care Unit for post-
operative monitoring, circulatory, and ventilatory support.
Preoperative kidney dysfunction and postoperative AKI
All individuals with a GFRo60 ml/min per 1.73 m2, irrespective of
the presence or absence of kidney damage, were classified as
having chronic kidney disease in accordance with the National
Kidney Foundation Guidelines.40 Postoperative AKI was defined
according to the AKIN classification (Table 1).41 The AKIN
classification provides three grades of postoperative AKI of
increasing severity (stage 1, stage 2, and stage 3) and is based on
relative changes in either serum creatinine or urine output
(whichever is the worst) compared with baseline (preoperative)
levels. All patients requiring (transient) postoperative dialysis were
classified as stage 3 AKI, irrespective of creatinine change. We
stratified patients into the AKIN stages based on creatinine changes
because of the fact that urine output data was not sufficiently
recorded in all patients.
Blood sampling, urine sampling, and sample processing
Arterial blood was collected preoperatively and at eight preset
perioperative time points; T1, preoperative; T2, before start of
cardiopulmonary bypass; T3, end of cardiopulmonary bypass; T4,
15 min reperfusion (15 min after cessation of cardiopulmonary
bypass); T5, 2 h reperfusion; T6, 6 h reperfusion; T7, day 1
postoperatively; and T8, day 2 postoperatively. Whole blood was
collected in EDTA vacutainers (Becton Dickinson, Franklin Lakes,
NJ, USA). Simultaneously, a fresh spot urine sample was collected
from the bladder catheter. Whole blood and urine samples were
immediately put on ice and centrifuged within 15 min after
collection (1500 g at 41C for 15 min), aliquoted, and stored at
801C until further analysis.
Laboratory analysis of hemolysis and renal tubular damage
fHb concentrations, indicating hemolysis, were measured in all
patients (N¼ 35) by derivative spectrometry as described else-
where.42 The detection limit of the assay was 2 mmol/l.
To assess renal tubular damage, urinary NAG concentrations
were determined by an enzyme colorimetric assay according to
the manufacturer’s instructions (HaemoScan, Groningen, The
Netherlands). NAG is excreted predominantly by the proximal renal
tubular cells. Owing to its relatively large molecular weight
(4130 kDa), high levels of urinary NAG preclude glomerular
filtration. Therefore, increased levels of NAG imply renal tubular
damage. Furthermore, NAG is not reabsorbed by the tubules.43
Results were normalized to urinary creatinine values and expressed
as Units/mmol creatinine.
Statistics
Continuous data were presented as median (interquartile range
from the 25th to the 75th percentile) or mean±s.d, depending on
Gaussian distribution (checked using histograms and normal Q–Q
plots), and as N (%) for dichotomous data. Differences in patient
characteristics between study groups were compared using Pearson’s
w2 test with Fisher’s correction, when appropriate, for dichotomous
variables. Continuous data were analyzed using independent sample
t-test or Mann–Whitney U-test depending on Gaussian distribution.
Subsequently, changes in fHb and NAG levels compared with
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preoperative values were tested using the paired t-test. To
characterize the total amount of hemolysis and tubular injury
during the study period, the AUC for log-normalized fHb (AUCfHb)
and NAG (AUCNAG) was calculated for each patient using
trapezoidal analysis with time as a baseline. Subsequently, the
correlation between hemolysis and tubular injury was analyzed
using Pearson’s correlation in the total patient population (N¼ 35)
and subgroups of AKI and non-AKI. To correct for other risk
factors, the relationship between AUCNAG and AUCfHb, and the
relationship between NAG values and changes in perioperative
serum creatinine levels were assessed by multivariable linear
regression analysis (raw data were used). On the basis of the
number of included patients, we could adjust for three other
covariates in the latter multivariable linear regression analysis. To
analyze the predictive value of plasma fHb and urinary NAG for
AKI, receiver-operating characteristics curves were drawn by
plotting sensitivity values against 1-specificity for all possible
thresholds. The overall accuracy of the markers in detecting AKI
was represented by AUC. Best cutoff points were defined as the
maximum sum of sensitivity and specificity. Statistical calculations
were made using SPSS 15.0 for Windows (SPSS, Chicago, IL, USA),
and Prism 4.03 for Windows (GraphPad Software, San Diego, CA,
USA). A P-value o0.05 was considered to indicate statistical
significance.
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